Accretion Nutraveda H1 FY27 results: revenue Rs 2,944.47 lakh, PAT Rs 472.81 lakh
Accretion Nutraveda’s standalone half-year ended 30-09-26 revenue rose to Rs 2,944.47 lakh and profit after tax to Rs 472.81 lakh versus Rs 1,406.46 lakh and Rs 238.00 lakh a year earlier.
Key takeaways
- Revenue from operations was Rs 2,944.47 lakh vs Rs 1,406.46 lakh a year earlier.
- Total income rose to Rs 2,960.26 lakh from Rs 1,406.55 lakh in the prior half year.
- Profit before tax was Rs 569.00 lakh vs Rs 291.08 lakh in the half year ended 30-09-25.
- Profit for the period increased to Rs 472.81 lakh from Rs 238.00 lakh a year earlier.
- Basic and diluted EPS were Rs 6.53 vs Rs 4.83 in the corresponding half year.
H1 FY27 · standalone
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 2,944.47 lakh | Rs 1,406.46 lakh | +109.4% |
| PAT | Rs 472.81 lakh | Rs 238.00 lakh | +98.7% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 16.06% of revenue, down 86 bps from 16.92%.
- Total expenses rose 114.4% while revenue rose 109.4%.
- Cost of materials accounted for Rs 1,218.05 lakh of the Rs 1,275.79 lakh rise in total expenses (95%).
- Cost of materials took 73.6% of revenue, against 67.5% a year earlier.
Key standalone numbers (half-year ended 30-09-26)
From the unaudited statement of standalone financial results for the half year / year ended September 30, 2026:
- Revenue from operations: Rs 2,944.47 lakh (30-09-25: Rs 1,406.46 lakh)
- Other income: Rs 15.78 lakh (30-09-25: Rs 0.09 lakh)
- Total income (I+II): Rs 2,960.26 lakh (30-09-25: Rs 1,406.55 lakh)
- Cost of material consumed: Rs 2,167.62 lakh (30-09-25: Rs 949.57 lakh)
- Purchases: Rs 0.00 lakh (30-09-25: Rs 0.00 lakh)
- Changes in inventories of finished goods, work-in-progress and stock-in-trade: Rs (33.95) lakh (30-09-25: Rs 7.03 lakh)
- Employee benefits expenses: Rs 63.52 lakh (30-09-25: Rs 37.48 lakh)
- Finance costs: Rs 40.59 lakh (30-09-25: Rs 26.18 lakh)
- Depreciation and amortization expense: Rs 16.69 lakh (30-09-25: Rs 15.80 lakh)
- Other expenses: Rs 136.80 lakh (30-09-25: Rs 78.61 lakh)
- Total expense: Rs 2,391.26 lakh (30-09-25: Rs 1,115.47 lakh)
- Profit before exceptional and extraordinary items and tax (V): Rs 569.00 lakh (30-09-25: Rs 291.08 lakh)
- Exceptional items: Rs 0.00 lakh (30-09-25: Rs 0.00 lakh)
- Profit before extraordinary items and tax (VII): Rs 569.00 lakh (30-09-25: Rs 291.08 lakh)
- Extraordinary items: Rs 0.00 lakh (30-09-25: Rs 0.00 lakh)
- Profit before tax (IX): Rs 569.00 lakh (30-09-25: Rs 291.08 lakh)
- Total tax expense: Rs 96.19 lakh (30-09-25: Rs 53.08 lakh)
- Profit for the period from continuing operations (XI): Rs 472.81 lakh (30-09-25: Rs 238.00 lakh)
- Profit for the period (XV): Rs 472.81 lakh (30-09-25: Rs 238.00 lakh)
- Paid up share capital (face value Rs 10/share): Rs 724.00 lakh (30-09-25: Rs 532.00 lakh)
- Earnings per equity share – Basic: Rs 6.53 (30-09-25: Rs 4.83)
- Earnings per equity share – Diluted: Rs 6.53 (30-09-25: Rs 4.83)
According to the statement of financial results, standalone revenue from operations for the half year ended 30-09-26 increased to Rs 2,944.47 lakh from Rs 1,406.46 lakh in the half year ended 30-09-25. Including other income, total income rose to Rs 2,960.26 lakh from Rs 1,406.55 lakh over the same period.
On the cost side, cost of material consumed moved up to Rs 2,167.62 lakh from Rs 949.57 lakh, while total expense increased to Rs 2,391.26 lakh from Rs 1,115.47 lakh. After expenses, profit before tax for the half year stood at Rs 569.00 lakh compared with Rs 291.08 lakh a year earlier. Total tax expense was Rs 96.19 lakh versus Rs 53.08 lakh.
This resulted in profit for the period (profit after tax) of Rs 472.81 lakh for the half year ended 30-09-26, up from Rs 238.00 lakh in the corresponding half year. The company reported basic and diluted earnings per equity share of Rs 6.53, compared with Rs 4.83 in the half year ended 30-09-25, on a paid up share capital of Rs 724.00 lakh versus Rs 532.00 lakh a year earlier, as disclosed in the statement of financial results.
Track Accretion Nutraveda Ltd
Cruxal reads every Accretion Nutraveda Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
